By 2025, innovations such as lab-on-a-chip technology, automation, and CRISPR-Cas9 gene editing are expected to enhance ...

By editing the polymers of discarded plastics, chemists have found a way to generate new macromolecules with more valuable properties than those of the starting material. Upcycling may help remedy the ...

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

These cheap shares may be takeover targets in 2025, and as such, potentially offer shareholders the chance to earn outsized returns. The post 2 cheap shares that could be takeover targets in 2025 ...

Position size is a critical component of any trading strategy. Swing trading is no exception. With Interactive Brokers stock ...

Rating upgraded from 74 to 83 Friday. This unique rating tracks market leadership by showing how a stock's price action over ...

The scientific team at the laboratory is headed by a group of women with a track record in genomic science, molecular ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Ribosomal translation is the process by which cells synthesize proteins based on the genetic instructions encoded in messenger RNA. It is essential for life, yet it is an incredibly complex process ...

Varshavski: What's interesting about Proteus syndrome is it affects all three cell lines -- which is the endoderm, mesoderm, ...